Lipids QA/QI results

Intro

Results might change a little bit as we clean data more but should not change too much and I assume that we our statistical significance / insignificance will remain where it is now.

Figure 1

For now it is in the format that we had in our manuscript, I will likely change it so the bars PRE and POST intervention are by the side with p values above them on the graph.

##   [1] ASCVD-risk only       very high risk ASCVD  very high risk ASCVD 
##   [4] very high risk ASCVD  ASCVD-risk only       ASCVD-risk only      
##   [7] Clinical ASCVD        ASCVD-risk only       ASCVD-risk only      
##  [10] very high risk ASCVD  ASCVD-risk only       Clinical ASCVD       
##  [13] very high risk ASCVD  Clinical ASCVD        very high risk ASCVD 
##  [16] Diabetic, 40-75 years Diabetic, 40-75 years Diabetic, 40-75 years
##  [19] ASCVD-risk only       very high risk ASCVD  ASCVD-risk only      
##  [22] very high risk ASCVD  ASCVD-risk only       Clinical ASCVD       
##  [25] very high risk ASCVD  ASCVD-risk only       ASCVD-risk only      
##  [28] ASCVD-risk only       Clinical ASCVD        very high risk ASCVD 
##  [31] ASCVD-risk only       Diabetic, 40-75 years ASCVD-risk only      
##  [34] very high risk ASCVD  very high risk ASCVD  Diabetic, 40-75 years
##  [37] Diabetic, 40-75 years ASCVD-risk only       very high risk ASCVD 
##  [40] Diabetic, 40-75 years ASCVD-risk only       Clinical ASCVD       
##  [43] very high risk ASCVD  very high risk ASCVD  very high risk ASCVD 
##  [46] LDL-C >190mg/dL       ASCVD-risk only       Diabetic, 40-75 years
##  [49] ASCVD-risk only       Clinical ASCVD        ASCVD-risk only      
##  [52] very high risk ASCVD  ASCVD-risk only       Diabetic, 40-75 years
##  [55] very high risk ASCVD  ASCVD-risk only       Diabetic, 40-75 years
##  [58] ASCVD-risk only       very high risk ASCVD  Clinical ASCVD       
##  [61] ASCVD-risk only       Diabetic, 40-75 years Diabetic, 40-75 years
##  [64] ASCVD-risk only       Diabetic, 40-75 years very high risk ASCVD 
##  [67] very high risk ASCVD  ASCVD-risk only       ASCVD-risk only      
##  [70] Diabetic, 40-75 years very high risk ASCVD  ASCVD-risk only      
##  [73] Diabetic, 40-75 years Diabetic, 40-75 years Diabetic, 40-75 years
##  [76] ASCVD-risk only       Clinical ASCVD        ASCVD-risk only      
##  [79] ASCVD-risk only       very high risk ASCVD  Diabetic, 40-75 years
##  [82] Diabetic, 40-75 years ASCVD-risk only       Diabetic, 40-75 years
##  [85] very high risk ASCVD  LDL-C >190mg/dL       very high risk ASCVD 
##  [88] ASCVD-risk only       ASCVD-risk only       very high risk ASCVD 
##  [91] ASCVD-risk only       Clinical ASCVD        ASCVD-risk only      
##  [94] ASCVD-risk only       very high risk ASCVD  ASCVD-risk only      
##  [97] very high risk ASCVD  Clinical ASCVD        ASCVD-risk only      
## [100] Diabetic, 40-75 years ASCVD-risk only       very high risk ASCVD 
## [103] very high risk ASCVD  Diabetic, 40-75 years Diabetic, 40-75 years
## [106] ASCVD-risk only       ASCVD-risk only       ASCVD-risk only      
## [109] very high risk ASCVD  very high risk ASCVD  Diabetic, 40-75 years
## [112] ASCVD-risk only       very high risk ASCVD  very high risk ASCVD 
## [115] very high risk ASCVD  ASCVD-risk only       Diabetic, 40-75 years
## [118] Diabetic, 40-75 years Clinical ASCVD        Diabetic, 40-75 years
## [121] very high risk ASCVD  ASCVD-risk only       ASCVD-risk only      
## [124] Clinical ASCVD        ASCVD-risk only       very high risk ASCVD 
## [127] Diabetic, 40-75 years ASCVD-risk only       ASCVD-risk only      
## [130] ASCVD-risk only       Diabetic, 40-75 years Diabetic, 40-75 years
## [133] Diabetic, 40-75 years Clinical ASCVD        very high risk ASCVD 
## [136] ASCVD-risk only       Diabetic, 40-75 years Diabetic, 40-75 years
## [139] very high risk ASCVD  Diabetic, 40-75 years Diabetic, 40-75 years
## [142] ASCVD-risk only       Diabetic, 40-75 years Clinical ASCVD       
## [145] Diabetic, 40-75 years very high risk ASCVD  ASCVD-risk only      
## [148] Diabetic, 40-75 years Diabetic, 40-75 years Diabetic, 40-75 years
## [151] Clinical ASCVD        Diabetic, 40-75 years ASCVD-risk only      
## [154] ASCVD-risk only       Diabetic, 40-75 years ASCVD-risk only      
## [157] ASCVD-risk only       Diabetic, 40-75 years Diabetic, 40-75 years
## [160] ASCVD-risk only       very high risk ASCVD  ASCVD-risk only      
## [163] LDL-C >190mg/dL       ASCVD-risk only       ASCVD-risk only      
## [166] Diabetic, 40-75 years very high risk ASCVD  ASCVD-risk only      
## [169] Diabetic, 40-75 years Clinical ASCVD        Clinical ASCVD       
## [172] Diabetic, 40-75 years LDL-C >190mg/dL       Diabetic, 40-75 years
## [175] ASCVD-risk only       ASCVD-risk only       ASCVD-risk only      
## [178] Diabetic, 40-75 years ASCVD-risk only       ASCVD-risk only      
## [181] Diabetic, 40-75 years very high risk ASCVD  ASCVD-risk only      
## [184] ASCVD-risk only       ASCVD-risk only       ASCVD-risk only      
## [187] ASCVD-risk only       very high risk ASCVD  ASCVD-risk only      
## [190] Diabetic, 40-75 years very high risk ASCVD  very high risk ASCVD 
## [193] ASCVD-risk only       Diabetic, 40-75 years Diabetic, 40-75 years
## [196] Diabetic, 40-75 years very high risk ASCVD  Diabetic, 40-75 years
## [199] ASCVD-risk only       LDL-C >190mg/dL       Diabetic, 40-75 years
## [202] ASCVD-risk only       very high risk ASCVD  Diabetic, 40-75 years
## [205] Diabetic, 40-75 years Diabetic, 40-75 years Clinical ASCVD       
## [208] ASCVD-risk only       LDL-C >190mg/dL       Clinical ASCVD       
## [211] ASCVD-risk only       Clinical ASCVD        very high risk ASCVD 
## [214] ASCVD-risk only       very high risk ASCVD  ASCVD-risk only      
## [217] Diabetic, 40-75 years ASCVD-risk only       Diabetic, 40-75 years
## [220] very high risk ASCVD  ASCVD-risk only       Diabetic, 40-75 years
## [223] Diabetic, 40-75 years very high risk ASCVD  Clinical ASCVD       
## [226] Diabetic, 40-75 years Diabetic, 40-75 years ASCVD-risk only      
## [229] ASCVD-risk only       ASCVD-risk only       Diabetic, 40-75 years
## [232] ASCVD-risk only       ASCVD-risk only       ASCVD-risk only      
## [235] very high risk ASCVD  ASCVD-risk only       Diabetic, 40-75 years
## [238] Diabetic, 40-75 years ASCVD-risk only       ASCVD-risk only      
## [241] Diabetic, 40-75 years Diabetic, 40-75 years LDL-C >190mg/dL      
## [244] Diabetic, 40-75 years Diabetic, 40-75 years Clinical ASCVD       
## [247] very high risk ASCVD  ASCVD-risk only       very high risk ASCVD 
## [250] ASCVD-risk only       ASCVD-risk only       ASCVD-risk only      
## [253] ASCVD-risk only       ASCVD-risk only       very high risk ASCVD 
## [256] Clinical ASCVD        Diabetic, 40-75 years ASCVD-risk only      
## [259] Diabetic, 40-75 years ASCVD-risk only       ASCVD-risk only      
## [262] Diabetic, 40-75 years very high risk ASCVD  Diabetic, 40-75 years
## [265] ASCVD-risk only       Diabetic, 40-75 years ASCVD-risk only      
## [268] Diabetic, 40-75 years very high risk ASCVD  Diabetic, 40-75 years
## [271] Diabetic, 40-75 years Clinical ASCVD        ASCVD-risk only      
## [274] Diabetic, 40-75 years Diabetic, 40-75 years ASCVD-risk only      
## [277] Diabetic, 40-75 years Diabetic, 40-75 years Diabetic, 40-75 years
## [280] LDL-C >190mg/dL       Diabetic, 40-75 years ASCVD-risk only      
## [283] very high risk ASCVD  Clinical ASCVD        ASCVD-risk only      
## [286] Clinical ASCVD        Diabetic, 40-75 years ASCVD-risk only      
## [289] Diabetic, 40-75 years very high risk ASCVD  Diabetic, 40-75 years
## [292] ASCVD-risk only       Diabetic, 40-75 years Clinical ASCVD       
## [295] Diabetic, 40-75 years Diabetic, 40-75 years ASCVD-risk only      
## [298] Diabetic, 40-75 years Clinical ASCVD        very high risk ASCVD 
## [301] ASCVD-risk only       Diabetic, 40-75 years Clinical ASCVD       
## [304] Diabetic, 40-75 years ASCVD-risk only       very high risk ASCVD 
## [307] Diabetic, 40-75 years Diabetic, 40-75 years very high risk ASCVD 
## [310] LDL-C >190mg/dL       ASCVD-risk only       ASCVD-risk only      
## [313] Diabetic, 40-75 years Clinical ASCVD        Diabetic, 40-75 years
## [316] ASCVD-risk only       ASCVD-risk only       Diabetic, 40-75 years
## [319] Diabetic, 40-75 years very high risk ASCVD  ASCVD-risk only      
## [322] Diabetic, 40-75 years very high risk ASCVD  ASCVD-risk only      
## [325] ASCVD-risk only       ASCVD-risk only       ASCVD-risk only      
## [328] ASCVD-risk only       ASCVD-risk only       ASCVD-risk only      
## [331] Diabetic, 40-75 years Diabetic, 40-75 years Diabetic, 40-75 years
## [334] ASCVD-risk only       Diabetic, 40-75 years ASCVD-risk only      
## [337] ASCVD-risk only       very high risk ASCVD  ASCVD-risk only      
## [340] ASCVD-risk only       ASCVD-risk only       very high risk ASCVD 
## [343] Diabetic, 40-75 years Clinical ASCVD        ASCVD-risk only      
## [346] ASCVD-risk only       Diabetic, 40-75 years Diabetic, 40-75 years
## [349] very high risk ASCVD  Diabetic, 40-75 years ASCVD-risk only      
## [352] Diabetic, 40-75 years very high risk ASCVD  ASCVD-risk only      
## [355] Diabetic, 40-75 years Diabetic, 40-75 years Clinical ASCVD       
## [358] ASCVD-risk only       Diabetic, 40-75 years ASCVD-risk only      
## [361] ASCVD-risk only       Clinical ASCVD        very high risk ASCVD 
## [364] Diabetic, 40-75 years ASCVD-risk only       ASCVD-risk only      
## [367] ASCVD-risk only       ASCVD-risk only       Diabetic, 40-75 years
## [370] ASCVD-risk only       ASCVD-risk only       Diabetic, 40-75 years
## [373] ASCVD-risk only       ASCVD-risk only       Clinical ASCVD       
## [376] very high risk ASCVD  very high risk ASCVD  ASCVD-risk only      
## [379] ASCVD-risk only       Clinical ASCVD        ASCVD-risk only      
## [382] Diabetic, 40-75 years very high risk ASCVD  ASCVD-risk only      
## [385] ASCVD-risk only       Diabetic, 40-75 years Diabetic, 40-75 years
## [388] ASCVD-risk only       ASCVD-risk only       ASCVD-risk only      
## [391] Diabetic, 40-75 years Diabetic, 40-75 years ASCVD-risk only      
## [394] ASCVD-risk only       Diabetic, 40-75 years ASCVD-risk only      
## [397] Diabetic, 40-75 years Diabetic, 40-75 years ASCVD-risk only      
## [400] Clinical ASCVD        Diabetic, 40-75 years LDL-C >190mg/dL      
## [403] ASCVD-risk only       ASCVD-risk only       Diabetic, 40-75 years
## [406] Diabetic, 40-75 years Diabetic, 40-75 years Diabetic, 40-75 years
## [409] Diabetic, 40-75 years Diabetic, 40-75 years ASCVD-risk only      
## [412] ASCVD-risk only       ASCVD-risk only       ASCVD-risk only      
## [415] ASCVD-risk only       Diabetic, 40-75 years Clinical ASCVD       
## [418] ASCVD-risk only       ASCVD-risk only       ASCVD-risk only      
## [421] ASCVD-risk only       very high risk ASCVD  ASCVD-risk only      
## [424] Diabetic, 40-75 years Diabetic, 40-75 years Diabetic, 40-75 years
## [427] very high risk ASCVD  Diabetic, 40-75 years Clinical ASCVD       
## [430] ASCVD-risk only       Clinical ASCVD        ASCVD-risk only      
## [433] ASCVD-risk only       Diabetic, 40-75 years ASCVD-risk only      
## [436] Diabetic, 40-75 years Clinical ASCVD        ASCVD-risk only      
## [439] ASCVD-risk only       very high risk ASCVD  Diabetic, 40-75 years
## [442] Diabetic, 40-75 years very high risk ASCVD  ASCVD-risk only      
## [445] Clinical ASCVD        ASCVD-risk only       ASCVD-risk only      
## [448] ASCVD-risk only       Clinical ASCVD        ASCVD-risk only      
## [451] ASCVD-risk only       ASCVD-risk only       Clinical ASCVD       
## [454] ASCVD-risk only       Diabetic, 40-75 years Clinical ASCVD       
## [457] Clinical ASCVD        Clinical ASCVD        ASCVD-risk only      
## [460] Diabetic, 40-75 years Clinical ASCVD        ASCVD-risk only      
## [463] Diabetic, 40-75 years ASCVD-risk only       Diabetic, 40-75 years
## [466] Diabetic, 40-75 years ASCVD-risk only       ASCVD-risk only      
## [469] Diabetic, 40-75 years Clinical ASCVD        very high risk ASCVD 
## [472] ASCVD-risk only       ASCVD-risk only       Diabetic, 40-75 years
## [475] ASCVD-risk only       Diabetic, 40-75 years very high risk ASCVD 
## [478] Diabetic, 40-75 years ASCVD-risk only       very high risk ASCVD 
## [481] very high risk ASCVD  ASCVD-risk only       Diabetic, 40-75 years
## [484] Diabetic, 40-75 years Clinical ASCVD        Clinical ASCVD       
## [487] Diabetic, 40-75 years very high risk ASCVD  ASCVD-risk only      
## [490] very high risk ASCVD  Diabetic, 40-75 years ASCVD-risk only      
## [493] very high risk ASCVD  very high risk ASCVD  ASCVD-risk only      
## [496] ASCVD-risk only       Diabetic, 40-75 years ASCVD-risk only      
## [499] Diabetic, 40-75 years Clinical ASCVD        ASCVD-risk only      
## [502] Diabetic, 40-75 years very high risk ASCVD  Diabetic, 40-75 years
## [505] Diabetic, 40-75 years Diabetic, 40-75 years Diabetic, 40-75 years
## [508] ASCVD-risk only       Clinical ASCVD        Diabetic, 40-75 years
## [511] ASCVD-risk only       ASCVD-risk only       ASCVD-risk only      
## [514] Diabetic, 40-75 years Diabetic, 40-75 years Diabetic, 40-75 years
## [517] ASCVD-risk only       ASCVD-risk only       very high risk ASCVD 
## [520] ASCVD-risk only       very high risk ASCVD  Clinical ASCVD       
## [523] Diabetic, 40-75 years ASCVD-risk only       Diabetic, 40-75 years
## [526] LDL-C >190mg/dL       ASCVD-risk only       ASCVD-risk only      
## [529] Diabetic, 40-75 years very high risk ASCVD  very high risk ASCVD 
## [532] ASCVD-risk only       Diabetic, 40-75 years LDL-C >190mg/dL      
## [535] Diabetic, 40-75 years ASCVD-risk only       very high risk ASCVD 
## [538] Diabetic, 40-75 years ASCVD-risk only       ASCVD-risk only      
## [541] Diabetic, 40-75 years ASCVD-risk only       Diabetic, 40-75 years
## [544] Diabetic, 40-75 years Diabetic, 40-75 years ASCVD-risk only      
## [547] very high risk ASCVD  ASCVD-risk only       very high risk ASCVD 
## [550] very high risk ASCVD  Diabetic, 40-75 years LDL-C >190mg/dL      
## [553] Clinical ASCVD        very high risk ASCVD  ASCVD-risk only      
## [556] ASCVD-risk only       Diabetic, 40-75 years Diabetic, 40-75 years
## [559] ASCVD-risk only       Clinical ASCVD        Diabetic, 40-75 years
## [562] ASCVD-risk only       Clinical ASCVD        Clinical ASCVD       
## [565] Diabetic, 40-75 years ASCVD-risk only       very high risk ASCVD 
## [568] Diabetic, 40-75 years Clinical ASCVD        Diabetic, 40-75 years
## [571] ASCVD-risk only       Diabetic, 40-75 years Clinical ASCVD       
## [574] Diabetic, 40-75 years very high risk ASCVD  very high risk ASCVD 
## [577] ASCVD-risk only       very high risk ASCVD  Diabetic, 40-75 years
## [580] Clinical ASCVD        Diabetic, 40-75 years very high risk ASCVD 
## [583] Diabetic, 40-75 years Diabetic, 40-75 years Diabetic, 40-75 years
## [586] very high risk ASCVD  Diabetic, 40-75 years Diabetic, 40-75 years
## [589] Diabetic, 40-75 years Diabetic, 40-75 years Diabetic, 40-75 years
## [592] Diabetic, 40-75 years very high risk ASCVD  Clinical ASCVD       
## [595] ASCVD-risk only       ASCVD-risk only       very high risk ASCVD 
## [598] Clinical ASCVD        ASCVD-risk only       ASCVD-risk only      
## [601] ASCVD-risk only       Diabetic, 40-75 years very high risk ASCVD 
## [604] Diabetic, 40-75 years very high risk ASCVD  ASCVD-risk only      
## [607] very high risk ASCVD  Diabetic, 40-75 years Clinical ASCVD       
## [610] Clinical ASCVD        ASCVD-risk only       LDL-C >190mg/dL      
## [613] ASCVD-risk only       Clinical ASCVD        very high risk ASCVD 
## [616] very high risk ASCVD  Diabetic, 40-75 years Diabetic, 40-75 years
## [619] Clinical ASCVD        ASCVD-risk only       Diabetic, 40-75 years
## [622] Diabetic, 40-75 years ASCVD-risk only       Clinical ASCVD       
## [625] Diabetic, 40-75 years ASCVD-risk only       Diabetic, 40-75 years
## [628] ASCVD-risk only       Diabetic, 40-75 years Diabetic, 40-75 years
## [631] Diabetic, 40-75 years Clinical ASCVD        ASCVD-risk only      
## [634] very high risk ASCVD  Diabetic, 40-75 years Diabetic, 40-75 years
## [637] ASCVD-risk only       very high risk ASCVD  Diabetic, 40-75 years
## [640] Diabetic, 40-75 years ASCVD-risk only       Diabetic, 40-75 years
## [643] Clinical ASCVD        Diabetic, 40-75 years ASCVD-risk only      
## [646] ASCVD-risk only       Clinical ASCVD        Diabetic, 40-75 years
## [649] Diabetic, 40-75 years Diabetic, 40-75 years Diabetic, 40-75 years
## [652] Diabetic, 40-75 years Diabetic, 40-75 years ASCVD-risk only      
## [655] Diabetic, 40-75 years Diabetic, 40-75 years ASCVD-risk only      
## [658] Diabetic, 40-75 years very high risk ASCVD  Diabetic, 40-75 years
## [661] ASCVD-risk only       ASCVD-risk only       very high risk ASCVD 
## [664] ASCVD-risk only       Diabetic, 40-75 years ASCVD-risk only      
## [667] Clinical ASCVD        Diabetic, 40-75 years very high risk ASCVD 
## [670] very high risk ASCVD  Diabetic, 40-75 years Diabetic, 40-75 years
## [673] ASCVD-risk only       Diabetic, 40-75 years Diabetic, 40-75 years
## [676] ASCVD-risk only       LDL-C >190mg/dL       ASCVD-risk only      
## [679] very high risk ASCVD  ASCVD-risk only       Diabetic, 40-75 years
## [682] Clinical ASCVD        Diabetic, 40-75 years Diabetic, 40-75 years
## [685] Diabetic, 40-75 years ASCVD-risk only       very high risk ASCVD 
## [688] Diabetic, 40-75 years Diabetic, 40-75 years very high risk ASCVD 
## [691] Diabetic, 40-75 years Diabetic, 40-75 years Diabetic, 40-75 years
## [694] very high risk ASCVD  Diabetic, 40-75 years
## 5 Levels: ASCVD-risk only Clinical ASCVD ... LDL-C >190mg/dL

Table 1 (by incitation)

Table 1. Two-sample test for equality of proportions with continuity correction
name	n_pre	n_post	total_group_pre	total_group_post	percent_pre	percent_post	p.value	conf.low	conf.high
ASCVD-risk only	125	59	185	65	68	91	0.00049	-0.33989	-0.12414
Clinical ASCVD	46	25	48	25	96	100	0.77992	-0.12861	0.04528
very high risk ASCVD	73	42	76	42	96	100	0.48797	-0.10173	0.02279
Diabetic, 40-75 years	127	79	144	95	88	83	0.36126	-0.05024	0.15098
LDL-C >190mg/dL	10	5	10	5	100	100	NaN	0.00000	0.00000

We see a nice statistical significance in ASCVD-risk only, which is that our intervention was targeted. Of course it is only association likely not causation (likely not caused by intervention), but this is a nice result and I think it is good enough for an abstrace / QA/QI manuscript.

Figure 2 (all)

Table 2 (all)

Table 2. Two-sample test for equality of proportions with continuity correction
name	n_pre	n_post	total_group_pre	total_group_post	percent_pre	percent_post	p.value	conf.low	conf.high
all indications	381	210	463	232	82	91	0.00625	-0.13651	-0.02722

Big table pre VS post

This compares directly pre intervention to post intervention group so shows how well the randimization go, looks like preety well. And Giselle also mentioned something about how lipid testing was improved by intervention?

Characteristic	Overall, N = 695¹	Patients pre- and post- intervention		p-value²
Characteristic	Overall, N = 695¹	pre intervention, N = 463¹	post intervention, N = 232¹	p-value²
visit_provider_level				<0.001
Attending-only	4 (0.6%)	4 (0.9%)	0 (0%)
Resident w/ preceptor - PGY-1	160 (25%)	118 (25%)	42 (24%)
Resident w/ preceptor - PGY-2	225 (35%)	135 (29%)	90 (51%)
Resident w/ preceptor - PGY-3	252 (39%)	206 (44%)	46 (26%)
Unknown	54	0	54
attending_preceptor
Atkin	58 (9.3%)	52 (12%)	6 (3.4%)
Ayyala	40 (6.4%)	35 (7.8%)	5 (2.9%)
Doshi	81 (13%)	55 (12%)	26 (15%)
Fayngersh	49 (7.8%)	28 (6.2%)	21 (12%)
Fede	125 (20%)	99 (22%)	26 (15%)
Feurdean	12 (1.9%)	12 (2.7%)	0 (0%)
Gordon	76 (12%)	55 (12%)	21 (12%)
Matassa	73 (12%)	45 (10.0%)	28 (16%)
Natale-Pereira	1 (0.2%)	1 (0.2%)	0 (0%)
Pergament	66 (11%)	37 (8.2%)	29 (17%)
Sterling-Jean	45 (7.2%)	32 (7.1%)	13 (7.4%)
Unknown	69	12	57
Age, years	61 (55, 68)	61 (55, 68)	61 (54, 69)	0.4
Unknown	1	0	1
Male gender				0.6
Female	368 (53%)	249 (54%)	119 (52%)
Male	326 (47%)	214 (46%)	112 (48%)
Unknown	1	0	1
race				0.6
Asian	16 (4.2%)	9 (3.5%)	7 (5.7%)
Black or African American	323 (85%)	222 (86%)	101 (82%)
Native Hawaiian or Pacific Islander	1 (0.3%)	1 (0.4%)	0 (0%)
White	41 (11%)	26 (10%)	15 (12%)
Unknown	314	205	109
hispanic_or_latino_ethnicity	304 (44%)	211 (46%)	93 (42%)	0.3
Unknown	9	1	8
patient_primary_language				0.7
English	414 (60%)	284 (61%)	130 (56%)
French-Creole	7 (1.0%)	4 (0.9%)	3 (1.3%)
Other	24 (3.5%)	15 (3.2%)	9 (3.9%)
Portuguese	48 (6.9%)	31 (6.7%)	17 (7.4%)
Spanish	201 (29%)	129 (28%)	72 (31%)
Unknown	1	0	1
translator_service_used_or_physician_native_speaker	219 (79%)	126 (71%)	93 (92%)	<0.001
Unknown	417	286	131
charity_care_or_uninsured_patient	356 (51%)	253 (55%)	103 (45%)	0.013
Unknown	1	0	1
weight_kg	80 (70, 92)	80 (70, 91)	79 (69, 92)	0.8
Unknown	4	2	2
height_cent_imeters	165 (158, 173)	165 (158, 173)	165 (160, 173)	0.7
Unknown	8	3	5
bmi_kg_m_m	29 (26, 33)	29 (26, 33)	29 (26, 32)	0.5
Unknown	8	3	5
hypertension	564 (81%)	375 (81%)	189 (82%)	0.8
Unknown	1	0	1
diabetes_mellitus	335 (48%)	208 (45%)	127 (55%)	0.015
most_recent_hemoglobin_a1c_percent	7.30 (6.50, 9.30)	7.20 (6.50, 8.95)	7.45 (6.57, 9.62)	0.3
Unknown	376	268	108
chronic_kidney_disease	110 (16%)	71 (15%)	39 (17%)	0.6
dialysis	12 (1.7%)	10 (2.2%)	2 (0.9%)	0.4
coronary_artery_disease	114 (16%)	67 (14%)	47 (21%)	0.043
Unknown	3	0	3
history_of_mi	51 (7.3%)	32 (6.9%)	19 (8.2%)	0.5
Unknown	1	1	0
history_of_pci	57 (8.2%)	30 (6.5%)	27 (12%)	0.019
history_of_cabg	25 (3.6%)	15 (3.2%)	10 (4.3%)	0.5
history_of_cvd	100 (14%)	68 (15%)	32 (14%)	0.8
history_of_pad	22 (3.2%)	13 (2.8%)	9 (3.9%)	0.4
chronic_lung_disease	33 (4.8%)	20 (4.3%)	13 (5.7%)	0.4
Unknown	3	1	2
smoking				0.006
Current smoker OR quit <1 year	108 (16%)	83 (18%)	25 (11%)
Former smoker (quit > 1 year)	164 (24%)	117 (25%)	47 (20%)
Never-smoker	422 (61%)	263 (57%)	159 (69%)
Unknown	1	0	1
chf	87 (13%)	60 (13%)	27 (12%)	0.6
seen_by_cardiologist_within_12_months_of_encounter	210 (30%)	141 (31%)	69 (30%)	0.8
Unknown	1	1	0
clinical_ascvd	194 (28%)	124 (27%)	70 (30%)	0.3
type_of_ascvd_choice_acs				0.13
Checked	8 (1.2%)	3 (0.6%)	5 (2.2%)
Unchecked	687 (99%)	460 (99%)	227 (98%)
type_of_ascvd_choice_history_of_mi				0.6
Checked	49 (7.1%)	31 (6.7%)	18 (7.8%)
Unchecked	646 (93%)	432 (93%)	214 (92%)
ascvd hx unstable angina				0.2
Checked	16 (2.3%)	13 (2.8%)	3 (1.3%)
Unchecked	679 (98%)	450 (97%)	229 (99%)
ascvd hx cad				0.049
Checked	76 (11%)	43 (9.3%)	33 (14%)
Unchecked	619 (89%)	420 (91%)	199 (86%)
type_of_ascvd_choice_history_of_stroke_tia				0.5
Checked	101 (15%)	70 (15%)	31 (13%)
Unchecked	594 (85%)	393 (85%)	201 (87%)
type_of_ascvd_choice_history_of_pad				0.9
Checked	22 (3.2%)	15 (3.2%)	7 (3.0%)
Unchecked	673 (97%)	448 (97%)	225 (97%)
systolic_blood_pressure_in_index_visit	137 (124, 150)	137 (123, 150)	136 (126, 148)	0.7
Unknown	10	1	9
diastolic_blood_pressure_in_index_visit	72 (65, 81)	72 (65, 80)	73 (65, 82)	0.7
Unknown	10	1	9
treatment_for_hypertension	554 (80%)	371 (80%)	183 (79%)	0.7
Unknown	1	1	0
does_the_patient_have_an_indication_for_lipid_profile	684 (99%)	457 (99%)	227 (99%)	0.7
Unknown	3	1	2
lipid_profile_indication				<0.001
Diagnostic/treatment monitoring	405 (58%)	226 (49%)	179 (77%)
Screening	289 (42%)	237 (51%)	52 (23%)
Unknown	1	0	1
lipid_profile_available_ordered	673 (97%)	451 (97%)	222 (97%)	0.5
Unknown	2	0	2
10 yr ascvd calculated or known b4	272 (55%)	184 (55%)	88 (55%)	0.9
Unknown	199	126	73
can_10_year_ascvd_risk_be_calculated	445 (91%)	316 (95%)	129 (83%)	<0.001
Unknown	207	131	76
x10_year_ascvd_risk_percent	12 (8, 20)	12 (8, 20)	12 (7, 22)	>0.9
Unknown	243	146	97
cholesterol_total_mg_d_l	163 (132, 196)	162 (135, 196)	163 (129, 196)	0.6
Unknown	41	27	14
cholesterol_ldl_mg_d_l	85 (62, 120)	87 (64, 120)	81 (57, 116)	0.14
Unknown	24	10	14
cholesterol_hdl_mg_d_l	49 (41, 59)	50 (41, 59)	48 (41, 57)	0.4
Unknown	23	9	14
triglycerides_mg_d_l	106 (80, 153)	103 (78, 149)	112 (81, 170)	0.061
Unknown	23	10	13
lipid profile and ascvd performed while pt on statun	457 (69%)	304 (68%)	153 (71%)	0.4
Unknown	29	13	16
primary_statin_indication				0.013
ASCVD-risk only	250 (36%)	185 (40%)	65 (28%)
Clinical ASCVD	191 (27%)	124 (27%)	67 (29%)
Diabetic, 40-75 years	239 (34%)	144 (31%)	95 (41%)
LDL-C >190mg/dL	15 (2.2%)	10 (2.2%)	5 (2.2%)
is_a_high_intensity_statin_indicated	482 (70%)	323 (70%)	159 (71%)	0.8
Unknown	11	3	8
active_statin_treatment_at_end_of_visit				0.015
No	104 (15%)	82 (18%)	22 (9.5%)
Yes - prescribed during index visit	85 (12%)	53 (11%)	32 (14%)
Yes - prescribed during prior visit	506 (73%)	328 (71%)	178 (77%)
if_no_active_statin_treatment_despite_indication_provider_justification				>0.9
History of statin-associated muscle symptoms	2 (2.2%)	2 (2.5%)	0 (0%)
Other	91 (98%)	77 (97%)	14 (100%)
Unknown	602	384	218
is_the_statin_prescribed_of_adequate_indicated_intensity	519 (89%)	330 (87%)	189 (92%)	0.060
Unknown	111	84	27
if_incorrect_intensity_provider_justification				0.4
Maximally tolerated dose	3 (4.8%)	2 (4.1%)	1 (7.7%)
Other	56 (90%)	45 (92%)	11 (85%)
Patient preference	3 (4.8%)	2 (4.1%)	1 (7.7%)
Unknown	633	414	219
repeat lipid profile ordered to monitor statin adher	258 (44%)	126 (33%)	132 (64%)	<0.001
Unknown	111	85	26
if_available_repeat_ldl_c_mg_d_l_after_statin_initiation	81 (60, 96)	80 (58, 99)	83 (66, 94)	0.7
Unknown	576	388	188
very_high_risk_ascvd				0.10
0	1 (0.1%)	0 (0%)	1 (0.4%)
No	567 (82%)	385 (83%)	182 (78%)
Yes	127 (18%)	78 (17%)	49 (21%)
major_ascvd_events_choice_recent_acs_within_the_past_12_mo				0.6
Checked	4 (0.6%)	2 (0.4%)	2 (0.9%)
Unchecked	691 (99%)	461 (100%)	230 (99%)
major ascvd hx mi				0.4
Checked	49 (7.1%)	30 (6.5%)	19 (8.2%)
Unchecked	646 (93%)	433 (94%)	213 (92%)
major_ascvd_events_choice_history_of_ischemic_stroke				0.2
Checked	97 (14%)	70 (15%)	27 (12%)
Unchecked	598 (86%)	393 (85%)	205 (88%)
major_ascvd_events_choice_symptomatic_peripheral_arterial_disease				0.9
Checked	20 (2.9%)	13 (2.8%)	7 (3.0%)
Unchecked	675 (97%)	450 (97%)	225 (97%)
high_risk_conditions_choice_age_65_y				0.12
Checked	222 (32%)	139 (30%)	83 (36%)
Unchecked	473 (68%)	324 (70%)	149 (64%)
high_risk_conditions_choice_heterozygous_familial_hypercholesterolemia				>0.9
Checked	4 (0.6%)	3 (0.6%)	1 (0.4%)
Unchecked	691 (99%)	460 (99%)	231 (100%)
high_risk_conditions_choice_diabetes_mellitus				<0.001
Checked	343 (49%)	208 (45%)	135 (58%)
Unchecked	352 (51%)	255 (55%)	97 (42%)
high_risk_conditions_choice_hypertension				>0.9
Checked	570 (82%)	380 (82%)	190 (82%)
Unchecked	125 (18%)	83 (18%)	42 (18%)
high_risk_conditions_choice_ckd				0.8
Checked	109 (16%)	74 (16%)	35 (15%)
Unchecked	586 (84%)	389 (84%)	197 (85%)
high_risk_conditions_choice_current_smoking				0.2
Checked	80 (12%)	59 (13%)	21 (9.1%)
Unchecked	615 (88%)	404 (87%)	211 (91%)
high_risk_conditions_choice_persistently_elevated_ldl_c				0.004
Checked	14 (2.0%)	4 (0.9%)	10 (4.3%)
Unchecked	681 (98%)	459 (99%)	222 (96%)
high_risk_conditions_choice_history_of_congestive_hf				0.11
Checked	72 (10%)	54 (12%)	18 (7.8%)
Unchecked	623 (90%)	409 (88%)	214 (92%)
ezetimibe_indicated				<0.001
No	583 (84%)	392 (85%)	191 (83%)
Unable to assert	46 (6.7%)	18 (3.9%)	28 (12%)
Yes	61 (8.8%)	51 (11%)	10 (4.4%)
Unknown	5	2	3
pcsk9_inhibitor_indicated				<0.001
No	646 (93%)	442 (95%)	204 (89%)
Unable to assert	35 (5.1%)	10 (2.2%)	25 (11%)
Yes	11 (1.6%)	11 (2.4%)	0 (0%)
Unknown	3	0	3
coronary_artery_calcium_scoring_ordered	4 (0.6%)	4 (0.9%)	0 (0%)	0.3
Unknown	7	1	6
other_non_statin_therapies_choice_bile_acid_sequestrants
Unchecked	695 (100%)	463 (100%)	232 (100%)
other_non_statin_therapies_choice_niacin
Unchecked	695 (100%)	463 (100%)	232 (100%)
other_non_statin_therapies_choice_fibrates				>0.9
Checked	2 (0.3%)	1 (0.2%)	1 (0.4%)
Unchecked	693 (100%)	462 (100%)	231 (100%)
family_history_of_premature_ascvd	1 (0.1%)	1 (0.2%)	0 (0%)	>0.9
Unknown	4	0	4
chronic_inflammatory_conditions	30 (4.3%)	12 (2.6%)	18 (7.8%)	0.002
Unknown	2	1	1
south_asian_ancestry	7 (1.0%)	3 (0.6%)	4 (1.7%)	0.2
other_elevated_ascvd_associated_lipids_biomarkers	7 (1.0%)	2 (0.4%)	5 (2.2%)	0.044
Unknown	1	0	1
persistent_hypertriglyceridemia	27 (3.9%)	15 (3.2%)	12 (5.3%)	0.2
Unknown	5	1	4
on_statin				0.004
0	104 (15%)	82 (18%)	22 (9.5%)
1	591 (85%)	381 (82%)	210 (91%)
indication_modified				0.029
ASCVD-risk only	250 (36%)	185 (40%)	65 (28%)
Clinical ASCVD	73 (11%)	48 (10%)	25 (11%)
very high risk ASCVD	118 (17%)	76 (16%)	42 (18%)
Diabetic, 40-75 years	239 (34%)	144 (31%)	95 (41%)
LDL-C >190mg/dL	15 (2.2%)	10 (2.2%)	5 (2.2%)
real_race
Hispanic	304 (100%)	211 (100%)	93 (100%)
Unknown	391	252	139
race_true				0.6
Asian	16 (2.3%)	9 (1.9%)	7 (3.0%)
Black or African American	338 (49%)	219 (47%)	119 (51%)
Hispanic	304 (44%)	211 (46%)	93 (40%)
Native Hawaiian or Pacific Islander	1 (0.1%)	1 (0.2%)	0 (0%)
White	36 (5.2%)	23 (5.0%)	13 (5.6%)
race_white	36 (5.2%)	23 (5.0%)	13 (5.6%)	0.7
Black				0.3
0	357 (51%)	244 (53%)	113 (49%)
1	338 (49%)	219 (47%)	119 (51%)
race_hispanic	304 (44%)	211 (46%)	93 (40%)	0.2
indication_ldl	15 (2.2%)	10 (2.2%)	5 (2.2%)	>0.9
ASCVD risk > 7.5% only				0.002
0	445 (64%)	278 (60%)	167 (72%)
1	250 (36%)	185 (40%)	65 (28%)
indication_clinical_ascvd	191 (27%)	124 (27%)	67 (29%)	0.6
indication_diabetes	239 (34%)	144 (31%)	95 (41%)	0.010
translator_service_na_replaced				<0.001
0	417 (60%)	286 (62%)	131 (56%)
No	59 (8.5%)	51 (11%)	8 (3.4%)
Yes	219 (32%)	126 (27%)	93 (40%)
uninsured	356 (51%)	253 (55%)	103 (45%)	0.013
Unknown	1	0	1
ckd	110 (16%)	71 (15%)	39 (17%)	0.6
agecategor				0.5
(18,40]	19 (2.7%)	15 (3.2%)	4 (1.7%)
(40,55]	172 (25%)	113 (24%)	59 (26%)
(55,90]	503 (72%)	335 (72%)	168 (73%)
Unknown	1	0	1
¹ n (%); Median (IQR) ² Fisher's exact test; Wilcoxon rank sum test; Pearson's Chi-squared test

Big table only ASCVD

Characteristic	Overall, N = 250¹	Patients pre- and post- intervention		p-value²
Characteristic	Overall, N = 250¹	pre intervention, N = 185¹	post intervention, N = 65¹	p-value²
visit_provider_level				0.001
Attending-only	2 (0.8%)	2 (1.1%)	0 (0%)
Resident w/ preceptor - PGY-1	66 (28%)	50 (27%)	16 (29%)
Resident w/ preceptor - PGY-2	87 (36%)	57 (31%)	30 (55%)
Resident w/ preceptor - PGY-3	85 (35%)	76 (41%)	9 (16%)
Unknown	10	0	10
attending_preceptor
Atkin	12 (5.2%)	11 (6.2%)	1 (1.8%)
Ayyala	21 (9.0%)	19 (11%)	2 (3.6%)
Doshi	36 (15%)	25 (14%)	11 (20%)
Fayngersh	20 (8.6%)	12 (6.7%)	8 (15%)
Fede	47 (20%)	41 (23%)	6 (11%)
Feurdean	9 (3.9%)	9 (5.1%)	0 (0%)
Gordon	24 (10%)	18 (10%)	6 (11%)
Matassa	25 (11%)	16 (9.0%)	9 (16%)
Natale-Pereira	1 (0.4%)	1 (0.6%)	0 (0%)
Pergament	29 (12%)	19 (11%)	10 (18%)
Sterling-Jean	9 (3.9%)	7 (3.9%)	2 (3.6%)
Unknown	17	7	10
Age, years	64 (58, 69)	63 (58, 69)	64 (60, 70)	0.3
Unknown	1	0	1
Male gender				0.5
Female	126 (50%)	91 (49%)	35 (54%)
Male	124 (50%)	94 (51%)	30 (46%)
race				>0.9
Asian	3 (2.1%)	2 (1.9%)	1 (2.7%)
Black or African American	127 (88%)	94 (88%)	33 (89%)
Native Hawaiian or Pacific Islander	1 (0.7%)	1 (0.9%)	0 (0%)
White	13 (9.0%)	10 (9.3%)	3 (8.1%)
Unknown	106	78	28
hispanic_or_latino_ethnicity	100 (40%)	79 (43%)	21 (33%)	0.2
Unknown	2	0	2
patient_primary_language				0.6
English	151 (60%)	113 (61%)	38 (58%)
French-Creole	3 (1.2%)	2 (1.1%)	1 (1.5%)
Other	11 (4.4%)	7 (3.8%)	4 (6.2%)
Portuguese	16 (6.4%)	10 (5.4%)	6 (9.2%)
Spanish	69 (28%)	53 (29%)	16 (25%)
translator_service_used_or_physician_native_speaker	77 (78%)	52 (72%)	25 (93%)	0.030
Unknown	151	113	38
charity_care_or_uninsured_patient	135 (54%)	107 (58%)	28 (43%)	0.040
weight_kg	79 (70, 92)	78 (70, 91)	79 (68, 99)	0.7
height_cent_imeters	165 (160, 173)	165 (160, 173)	165 (160, 173)	0.7
bmi_kg_m_m	29 (25, 33)	29 (25, 33)	29 (25, 32)	>0.9
hypertension	201 (80%)	144 (78%)	57 (88%)	0.085
diabetes_mellitus	18 (7.2%)	15 (8.1%)	3 (4.6%)	0.4
most_recent_hemoglobin_a1c_percent	6.95 (5.90, 10.30)	7.70 (6.00, 11.50)	6.30 (5.95, 6.75)	0.4
Unknown	232	170	62
chronic_kidney_disease	26 (10%)	21 (11%)	5 (7.7%)	0.4
dialysis	2 (0.8%)	1 (0.5%)	1 (1.5%)	0.5
coronary_artery_disease	6 (2.4%)	5 (2.7%)	1 (1.6%)	>0.9
Unknown	1	0	1
history_of_mi
No	250 (100%)	185 (100%)	65 (100%)
history_of_pci
No	250 (100%)	185 (100%)	65 (100%)
history_of_cabg
No	250 (100%)	185 (100%)	65 (100%)
history_of_cvd	1 (0.4%)	1 (0.5%)	0 (0%)	>0.9
history_of_pad
No	250 (100%)	185 (100%)	65 (100%)
chronic_lung_disease	10 (4.0%)	7 (3.8%)	3 (4.6%)	0.7
Unknown	1	1	0
smoking				0.031
Current smoker OR quit <1 year	41 (16%)	37 (20%)	4 (6.2%)
Former smoker (quit > 1 year)	62 (25%)	46 (25%)	16 (25%)
Never-smoker	146 (59%)	102 (55%)	44 (69%)
Unknown	1	0	1
chf	28 (11%)	21 (11%)	7 (11%)	0.9
seen_by_cardiologist_within_12_months_of_encounter	52 (21%)	43 (23%)	9 (14%)	0.11
clinical_ascvd
No	250 (100%)	185 (100%)	65 (100%)
type_of_ascvd_choice_acs
Unchecked	250 (100%)	185 (100%)	65 (100%)
type_of_ascvd_choice_history_of_mi
Unchecked	250 (100%)	185 (100%)	65 (100%)
ascvd hx unstable angina
Unchecked	250 (100%)	185 (100%)	65 (100%)
ascvd hx cad
Unchecked	250 (100%)	185 (100%)	65 (100%)
type_of_ascvd_choice_history_of_stroke_tia
Unchecked	250 (100%)	185 (100%)	65 (100%)
type_of_ascvd_choice_history_of_pad
Unchecked	250 (100%)	185 (100%)	65 (100%)
systolic_blood_pressure_in_index_visit	138 (128, 151)	138 (128, 150)	138 (130, 152)	0.6
Unknown	1	0	1
diastolic_blood_pressure_in_index_visit	74 (67, 82)	74 (67, 82)	74 (67, 83)	>0.9
Unknown	1	0	1
treatment_for_hypertension	194 (78%)	142 (77%)	52 (80%)	0.6
does_the_patient_have_an_indication_for_lipid_profile	246 (99%)	182 (98%)	64 (100%)	0.6
Unknown	1	0	1
lipid_profile_indication				<0.001
Diagnostic/treatment monitoring	108 (43%)	66 (36%)	42 (66%)
Screening	141 (57%)	119 (64%)	22 (34%)
Unknown	1	0	1
lipid_profile_available_ordered	243 (98%)	180 (97%)	63 (100%)	0.3
Unknown	2	0	2
10 yr ascvd calculated or known b4	154 (62%)	107 (58%)	47 (72%)	0.039
can_10_year_ascvd_risk_be_calculated	241 (99%)	181 (100%)	60 (95%)	0.017
Unknown	6	4	2
x10_year_ascvd_risk_percent	13 (9, 20)	12 (9, 20)	13 (8, 22)	0.8
Unknown	6	3	3
cholesterol_total_mg_d_l	177 (150, 209)	177 (150, 214)	174 (155, 199)	>0.9
cholesterol_ldl_mg_d_l	96 (73, 125)	96 (72, 128)	94 (74, 122)	0.8
Unknown	1	1	0
cholesterol_hdl_mg_d_l	51 (42, 62)	52 (43, 63)	51 (42, 58)	0.7
triglycerides_mg_d_l	103 (77, 152)	101 (78, 149)	104 (73, 173)	0.9
Unknown	1	1	0
lipid profile and ascvd performed while pt on statun	130 (52%)	90 (49%)	40 (62%)	0.087
Unknown	2	2	0
primary_statin_indication
ASCVD-risk only	250 (100%)	185 (100%)	65 (100%)
is_a_high_intensity_statin_indicated	110 (45%)	77 (42%)	33 (54%)	0.089
Unknown	4	0	4
active_statin_treatment_at_end_of_visit				<0.001
No	66 (26%)	60 (32%)	6 (9.2%)
Yes - prescribed during index visit	42 (17%)	25 (14%)	17 (26%)
Yes - prescribed during prior visit	142 (57%)	100 (54%)	42 (65%)
if_no_active_statin_treatment_despite_indication_provider_justification
Other	61 (100%)	58 (100%)	3 (100%)
Unknown	189	127	62
is_the_statin_prescribed_of_adequate_indicated_intensity	164 (90%)	113 (90%)	51 (88%)	0.6
Unknown	67	60	7
if_incorrect_intensity_provider_justification				>0.9
Other	18 (95%)	11 (92%)	7 (100%)
Patient preference	1 (5.3%)	1 (8.3%)	0 (0%)
Unknown	231	173	58
repeat lipid profile ordered to monitor statin adher	74 (40%)	40 (32%)	34 (59%)	<0.001
Unknown	67	60	7
if_available_repeat_ldl_c_mg_d_l_after_statin_initiation	83 (66, 96)	85 (65, 98)	82 (70, 88)	0.7
Unknown	215	160	55
very_high_risk_ascvd	1 (0.4%)	0 (0%)	1 (1.5%)	0.3
major_ascvd_events_choice_recent_acs_within_the_past_12_mo
Unchecked	250 (100%)	185 (100%)	65 (100%)
major ascvd hx mi
Unchecked	250 (100%)	185 (100%)	65 (100%)
major_ascvd_events_choice_history_of_ischemic_stroke
Unchecked	250 (100%)	185 (100%)	65 (100%)
major_ascvd_events_choice_symptomatic_peripheral_arterial_disease
Unchecked	250 (100%)	185 (100%)	65 (100%)
high_risk_conditions_choice_age_65_y				0.069
Checked	92 (37%)	62 (34%)	30 (46%)
Unchecked	158 (63%)	123 (66%)	35 (54%)
high_risk_conditions_choice_heterozygous_familial_hypercholesterolemia				>0.9
Checked	1 (0.4%)	1 (0.5%)	0 (0%)
Unchecked	249 (100%)	184 (99%)	65 (100%)
high_risk_conditions_choice_diabetes_mellitus				0.5
Checked	20 (8.0%)	16 (8.6%)	4 (6.2%)
Unchecked	230 (92%)	169 (91%)	61 (94%)
high_risk_conditions_choice_hypertension				0.045
Checked	202 (81%)	144 (78%)	58 (89%)
Unchecked	48 (19%)	41 (22%)	7 (11%)
high_risk_conditions_choice_ckd				0.050
Checked	28 (11%)	25 (14%)	3 (4.6%)
Unchecked	222 (89%)	160 (86%)	62 (95%)
high_risk_conditions_choice_current_smoking				0.11
Checked	29 (12%)	25 (14%)	4 (6.2%)
Unchecked	221 (88%)	160 (86%)	61 (94%)
high_risk_conditions_choice_persistently_elevated_ldl_c				0.041
Checked	6 (2.4%)	2 (1.1%)	4 (6.2%)
Unchecked	244 (98%)	183 (99%)	61 (94%)
high_risk_conditions_choice_history_of_congestive_hf				>0.9
Checked	24 (9.6%)	18 (9.7%)	6 (9.2%)
Unchecked	226 (90%)	167 (90%)	59 (91%)
ezetimibe_indicated				<0.001
No	229 (92%)	174 (95%)	55 (85%)
Unable to assert	14 (5.6%)	4 (2.2%)	10 (15%)
Yes	6 (2.4%)	6 (3.3%)	0 (0%)
Unknown	1	1	0
pcsk9_inhibitor_indicated				0.034
No	239 (96%)	180 (97%)	59 (91%)
Unable to assert	10 (4.0%)	4 (2.2%)	6 (9.2%)
Yes	1 (0.4%)	1 (0.5%)	0 (0%)
coronary_artery_calcium_scoring_ordered	1 (0.4%)	1 (0.5%)	0 (0%)	>0.9
Unknown	2	1	1
other_non_statin_therapies_choice_bile_acid_sequestrants
Unchecked	250 (100%)	185 (100%)	65 (100%)
other_non_statin_therapies_choice_niacin
Unchecked	250 (100%)	185 (100%)	65 (100%)
other_non_statin_therapies_choice_fibrates
Unchecked	250 (100%)	185 (100%)	65 (100%)
family_history_of_premature_ascvd
No	247 (100%)	185 (100%)	62 (100%)
Unknown	3	0	3
chronic_inflammatory_conditions	11 (4.4%)	6 (3.2%)	5 (7.7%)	0.2
south_asian_ancestry	1 (0.4%)	0 (0%)	1 (1.5%)	0.3
other_elevated_ascvd_associated_lipids_biomarkers	1 (0.4%)	0 (0%)	1 (1.6%)	0.3
Unknown	1	0	1
persistent_hypertriglyceridemia	10 (4.0%)	7 (3.8%)	3 (4.7%)	0.7
Unknown	2	1	1
on_statin				<0.001
0	66 (26%)	60 (32%)	6 (9.2%)
1	184 (74%)	125 (68%)	59 (91%)
indication_modified				>0.9
ASCVD-risk only	250 (100%)	185 (100%)	65 (100%)
Clinical ASCVD	0 (0%)	0 (0%)	0 (0%)
very high risk ASCVD	0 (0%)	0 (0%)	0 (0%)
Diabetic, 40-75 years	0 (0%)	0 (0%)	0 (0%)
LDL-C >190mg/dL	0 (0%)	0 (0%)	0 (0%)
real_race
Hispanic	100 (100%)	79 (100%)	21 (100%)
Unknown	150	106	44
race_true				0.5
Asian	3 (1.2%)	2 (1.1%)	1 (1.5%)
Black or African American	133 (53%)	93 (50%)	40 (62%)
Hispanic	100 (40%)	79 (43%)	21 (32%)
Native Hawaiian or Pacific Islander	1 (0.4%)	1 (0.5%)	0 (0%)
White	13 (5.2%)	10 (5.4%)	3 (4.6%)
race_white	13 (5.2%)	10 (5.4%)	3 (4.6%)	>0.9
Black				0.12
0	117 (47%)	92 (50%)	25 (38%)
1	133 (53%)	93 (50%)	40 (62%)
race_hispanic	100 (40%)	79 (43%)	21 (32%)	0.14
indication_ldl	0 (0%)	0 (0%)	0 (0%)
ASCVD risk > 7.5% only				>0.9
0	0 (0%)	0 (0%)	0 (0%)
1	250 (100%)	185 (100%)	65 (100%)
indication_clinical_ascvd	0 (0%)	0 (0%)	0 (0%)
indication_diabetes	0 (0%)	0 (0%)	0 (0%)
translator_service_na_replaced				0.082
0	151 (60%)	113 (61%)	38 (58%)
No	22 (8.8%)	20 (11%)	2 (3.1%)
Yes	77 (31%)	52 (28%)	25 (38%)
uninsured	135 (54%)	107 (58%)	28 (43%)	0.040
ckd	26 (10%)	21 (11%)	5 (7.7%)	0.4
agecategor				0.5
(18,40]	1 (0.4%)	1 (0.5%)	0 (0%)
(40,55]	38 (15%)	31 (17%)	7 (11%)
(55,90]	210 (84%)	153 (83%)	57 (89%)
Unknown	1	0	1
¹ n (%); Median (IQR) ² Fisher's exact test; Wilcoxon rank sum test; Pearson's Chi-squared test

MVA on OLD patients (pre intervention)

There are tiny differences between this and the manuscript result, I believe that the reason is that in manuscript he had 464 and here I am getting 463 patients pre-intervension, I would just ignore it.

MVA on NEW patients (post intervention)

I had to remove CKD because or model gets wild secondary to relatively smaller n than before. As expected we have much wider confidence intervals 2/2 smaller n.

MVA on ALL patients (pre and post intervention)

Misings / outliers

To fix

Checks of exclusion

These are not yet excluded:

Already excluded (from manuscript times + 3 current suggested by Sana):

## [1] "Active liver disease"                                 
## [2] "History of statin-associated myopathy/rhabdomyolysis" 
## [3] "History of statin-associated persistent transaminitis"
## [4] "Patient preference"

##  [1] "Allergic to statins - tried multiple"                 
##  [2] "Age"                                                  
##  [3] "age"                                                  
##  [4] "Awaiting LFTs to start statin"                        
##  [5] "Awaiting new lipid panel"                             
##  [6] "awaiting new lipid profile"                           
##  [7] "Awaiting new lipid profile"                           
##  [8] "following up results"                                 
##  [9] "getting another lipid profile"                        
## [10] "Lifestyles changes first"                             
## [11] "Repeat lipid profile"                                 
## [12] "Awaiting diet modifications to improve lipids"        
## [13] "hives associated with pravastatin"                    
## [14] "waiting until patient is 40 yo"                       
## [15] "unclear why not one it. perhaps young and teratogenic"